SNORD126

Across TCGA pan-cancer cohorts, SNORD126 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SNORD126 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher SNORD126 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD126 expression acts as an unfavorable survival marker, although some lineages such as READ show a favorable association.

OV, KIRP, and BRCA are the cancer types where SNORD126 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	All	0.516	0.716	<.001	120	view →
KIRP	OS	Tertile	All	0.809	0.944	<.001	93	view →
BRCA	DFS	Tertile	II,III,IV	0.327	0.556	.015	54	view →
ACC	DFS	Tertile	All	0.210	0.766	<.001	45	view →
KIRC	DFS	Tertile	IV	0.245	0.636	<.001	33	view →
ESCA	OS	Tertile	IV	0.143	0.668	.010	30	view →
LUAD	DFS	Tertile	IV	0.265	0.752	.002	21	view →
UCS	OS	Tertile	All	0.183	0.585	.043	18	view →
STAD	DFS	Quartile	IV	0.133	0.591	.024	15	view →
SKCM	DFS	Tertile	II,III,IV	0.474	0.726	.012	15	view →
SARC	OS	Tertile	All	0.164	0.517	.002	15	view →
LIHC	DFS	Tertile	All	0.261	0.573	<.001	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

SNORD126–OV (OS)

Open the OV breakdown →